Alcohol-use disorders (prevention)
Alcohol-use disorders - preventing the development of hazardous and harmful drinking.
|Expected date of issue:||June 2010|
NICE is developing three pieces of guidance relating to alcohol use disorders over the next two years. Each piece of guidance will focus on a different element of the care pathway, from the prevention and early identification of alcohol use disorders through to the clinical management of acute alcohol withdrawal and alcohol related liver disease and pancreatitis. The third piece of guidance will focus on the management of alcohol dependency and psychological interventions.
Because of the breadth of advice that will be covered and the short timescale in which NICE has to produce final recommendations, it will not be possible for one centre to develop all three pieces of guidance. Therefore, the topics have been allocated as follows:
Part 1 - Public health guidance
Alcohol use disorders in adults and young people: prevention and early identification (publication TBC) - Centre for Public Health Excellence (CPHE) at NICE
Part 2 - Clinical guideline
Alcohol use disorders in adults and young people: clinical management (publication expected May 2010) - National Collaborating Centre for Chronic Conditions (NCC-CC)
Part 3 - Clinical guideline
Alcohol dependence and harmful alcohol use (publication expected January 2011) - National Collaborating Centre for Mental Health (NCC-MH)
NICE has set up a steering committee to oversee the production of these pieces of guidance. This group, which will include development group members, staff from all three guidance-producing centres and senior NICE staff will identify and act on any gaps or overlaps across the different guidance topics in order to ensure that the final guidance produced is complementary and consistent.
As part of our normal process, NICE will set up independent guidance development groups, who will formulate recommendations. For public health programmes, members of the independent programme development group (PDG) are multidisciplinary, comprising healthcare professionals, technical experts, people working directly in public health, managers in the health service and other organisations, researchers and representatives from ‘lay' groups such as charities or patient/carer organisations. For clinical guidelines, members of the guideline development group (GDG) are multidisciplinary, comprising healthcare professionals, technical experts, and patients and/or carers. As with all of our guidance, NICE ensures that members of the guidance development groups carry a breadth of experience and expertise across a range of settings and specialities so the development of recommendations reflects the broad nature of support required by people affected by alcohol dependence.
This page provides more detail on the public health programme guidance. Please follow the earlier links to view details of the other pieces of guidance.
Consultation on additional evidence by stakeholders: 4 August - 1 September 2009
NICE project team
|Executive Lead:||Peter Littlejohns|
|Director:||Professor Mike Kelly|
|Associate Director:||Antony Morgan|
|Lead Analyst:||Dylan Jones|
|Project Manager:||Patricia Mountain|
|Communications Lead:||Paul Cooney|
|Implementation Lead:||Mandy Harling|
|Public involvement Lead:||Alix Johnson|
|Review Team:||ScHARR (School of Health and Related Research, University of Sheffield)|
|Project Email Address:||firstname.lastname@example.org|
|Consultation on draft scope by stakeholders:||4 April - 2 May 2008|
|Meeting with stakeholder organisations:||09 April 2008|
|Final scope published:||June 2008|
|Consultation on evidence synopsis and submission of evidence by stakeholders:||19 May - 17 June 2009|
|Consultation on draft guidance:||13 October - 10 November 2009|
|Expected date of issue:||June 2010|
National organisations wishing to register as a stakeholder can do so via the link below.
This page was last updated: 16 March 2012